- Home
- ALGS vs ZTEK Comparison
ALGS vs ZTEK Comparison
Compare ALGS & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALGS | ZTEK |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.0M | 68.8M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ALGS | ZTEK |
|---|---|---|
| Price | $7.04 | $0.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $47.00 | N/A |
| AVG Volume (30 Days) | 32.3K | ★ 126.5K |
| Earning Date | 03-05-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,186,000.00 | N/A |
| Revenue This Year | $4.99 | N/A |
| Revenue Next Year | $8.89 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.76 | $0.54 |
| 52 Week High | $13.69 | $1.84 |
Technical Indicators
Market Signals| Indicator | ALGS | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 45.47 | 38.04 |
| Support Level | $6.21 | $0.55 |
| Resistance Level | $8.42 | $0.75 |
| Average True Range (ATR) | 0.55 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 31.52 | 38.46 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.